Podcasts about physicians

Physician and professional certified coach Chrissie Ott discusses her article "How an insider advocate can save a loved one." Chrissie shares a terrifying recent story of a friend's elderly, Spanish-speaking mother who was admitted to the hospital and declined rapidly due to medication and dehydration, highlighting how the patient's daughter suspected abuse while the real, urgent medical issues were being missed. She explains how she acted as an "insider advocate," providing her friend with the exact script (including terms like "agitated delirium" and "acute kidney injury") and the escalation path needed to get her mother life-saving fluids. This episode is a critical look at how overworked hospital systems fail patients, why it's so hard for families to navigate a medical crisis, and the rising need for physician advocates to bridge the gap. Learn the language and the steps you need to take to effectively fight for your loved one and ensure they get the right care at the right time. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Disclaimer: This is a sponsored episode. Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show.  

On Mission Matters, Adam Torres with Todd Vande Hei, CEO of Stark Health; Dr. Resham Uttamchandani, Physician in Family & Obesity Medicine. Together, they break down what root-cause care really looks like—covering metabolic health, visceral fat, protein intake, GLP-1s, hormone therapy, and the lifestyle drivers that truly extend lifespan and healthspan. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices

We're exploring different objects on display in our Physicians' Gallery. This week, we're talking about the electro-therapeutic machine. These machines were designed to administer electric shocks. _______________ Follow us on: Bluesky - @physiciansgallery Instagram - @physiciansgallery TikTok - @physiciansgallery Facebook - www.facebook.com/PhysiciansGallery Sign up for our newsletter - www.rcpe.ac.uk/newsletter To support heritage at the RCPE, please donate: www.rcpe.ac.uk/donate _______________ The Team: Dr Charlotte Holmes (@_CCHolmes_) - Editor/Producer Rachel Forrest - Researcher/Presenter Dr Daisy Cunynghame - Researcher/Presenter Dr Sarah Hayward - Editor/Producer

We're exploring different objects on display in our Physicians' Gallery. This week, we're talking about the electro-therapeutic machine. These machines were designed to administer electric shocks. _______________ Follow us on: Bluesky - @physiciansgallery Instagram - @physiciansgallery TikTok - @physiciansgallery Facebook - www.facebook.com/PhysiciansGallery Sign up for our newsletter - www.rcpe.ac.uk/newsletter To support heritage at the RCPE, please donate: www.rcpe.ac.uk/donate _______________ The Team: Dr Charlotte Holmes (@_CCHolmes_) - Editor/Producer Rachel Forrest - Researcher/Presenter Dr Daisy Cunynghame - Researcher/Presenter Dr Sarah Hayward - Editor/Producer

In this episode, Scott Becker breaks down reasons physicians sell their practices to private equity; the need to cash out, hopes for stronger management, and situations where financial trouble forces a sale.

The post 145 GU Neoplasms. Only the pieces you need to pass. appeared first on Physician Assistant Exam Review.

Send us a textIn this powerful and timely episode of the Gotta Be Saints Podcast, I'm joined by Dr. Charles “Charlie” Camosy — moral theologian, bioethicist, and author of Living and Dying Well (order here).Charlie shares deep insights into the cultural push toward physician-assisted killing, why our society is at a “tipping point,” and how the Catholic vision of life and death offers a radically hopeful alternative rooted in dignity, community, and love. Drawing from Church teaching, real-world data, and his father's own end-of-life journey, Charlie shows how we can resist the throwaway culture and accompany the sick and elderly with compassion and purpose.Whether you're caring for aging parents, worried about dementia, or simply wondering what it means to “die well” as a disciple of Jesus, this conversation reframes aging and dying as invitations to deeper love.In this episode, Charlie shares:Why some states are pushing physician-assisted killing — and why others still strongly resistWhat “autonomy” really means in our cultural momentWhy the poor, disabled, and marginalized are most at riskHow consumerism distorts our view of productivity and worthWhat it truly means to live and die well in Christian communityHow demographic trends and the dementia crisis complicate end-of-life careHow Catholics can build a counterculture of hospitality, encounter, and hopeIf you've ever asked yourself…How do I support a loved one who fears being a burden? What does the Church actually teach about assisted suicide? How do I walk with aging parents with dignity and charity? What does resisting the throwaway culture look like at the end of life? …then this episode is for you.Learn MoreExplore more of Charlie's work: charlescamosy.comTruthlyThis episode is sponsored by Truthly — the first Catholic action app helping you reflect, learn, and share your faith confidently. Start your free trial with code gottabesaints: truthly.aiFollow Gotta Be SaintsInstagram: @gottabesaints Subscribe and leave a review to help others discover the call to holiness. Support the show

In this episode of the Money Meets Medicine podcast hosted by Justin Harvey and Dr. Jimmy Turner, the discussion centers on recent developments in physician finance, particularly around real estate syndication deals and capital calls. Dr. Turner delves into the financial pitfalls and lessons from particular real estate investments targeted at physicians. They discuss the concept of 'affinity fraud,' where trusted social or professional bonds are exploited for financial gain, and dissect why such investments are often riskier than they appear. The conversation also touches on the importance of understanding compensation models and incentives when receiving financial advice, the necessity of due diligence, and the role of being an accredited investor. Looking for own-occupation disability insurance? Get a quote from a company you can trust at https://moneymeetsmedicine.com/disabilityDownload a free copy of The Physician Philosopher's Guide to Personal Finance at https://moneymeetsmedicine.com/freebook  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Physician coach Michelle Chestovich MD shares tips on dealing with your crazy busy life!

This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.

The unprecedented payment cuts that the Centers for Medicare and Medicaid (CMS) proposed over the summer were finalized on October 31. The disastrous impact on cataract surgery reimbursements alone will amount to an 11% reduction in payment. In today's emergency episode, host Dr. Andrew Pouw welcomes back three guests to rally ophthalmologists to take action: Dr. John McAllister, the Academy's Secretary for Federal Affairs; Brandy Keys, the Academy's Director of Health Policy; and Rebecca Hyder, the Academy's Vice President of Government Affairs.  Physicians shouldn't have to choose between staying open and serving their Medicare patients. Congress needs to hear directly from ophthalmologists like you before these cuts are enacted. Please, make your voice heard. Use this easy form to reach Congress. Essential Academy Resources: Contact Congress Now: www.aao.org/act-now Summary of CMS Medicare Physician Fee Schedule Past podcast episode: CMS Cuts Rock Ophthalmology For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Dan Rubin, ND, FABNO, has been a pioneer in naturopathic oncology for nearly three decades. As the Founding President of the Oncology Association of Naturopathic Physicians, he helped define and standardize the field, bringing it recognition on an international stage. He is the co-founder and Medical Director of Naturopathic Specialists in Scottsdale, Arizona, a leading clinic that has served people from all 50 states and 19 countries. Known for his expertise in integrating traditional and naturopathic medicine, Dr. Rubin has been recognized as National Physician of the Year and continues to shape the future of integrative oncology through clinical care, teaching, and global collaboration. Dr. Dan Rubin has been at the forefront of naturopathic oncology for nearly 30 years. He co-founded Naturopathic Specialists in Scottsdale, Arizona, where people from all 50 states and nearly 20 countries have come for care. Back in 2004, he helped launch the Oncology Association of Naturopathic Physicians, setting the stage for how the field is defined and practiced today. Recognized nationally as Physician of the Year, Dr. Rubin is known for blending traditional and naturopathic medicine, teaching the next generation, and pushing the boundaries of integrative cancer care. Connect with Dr. Rubin: Website: listenandcare.com Instagram: @Naturopathicspecialistsllc Facebook: Naturopathic Specialists LLC Podcast: Rubinonpoint.com linktree: https://linktr.ee/naturopathicspecialists Phone: 480.990.1111 Email: hello@listenandcare.com ___________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.   To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _______________ Why does Dr. Linda Isaacs, M.D., a board-certified internist, offer an enzyme-based nutritional program for cancer patients? Decades of seeing people have much better outcomes than expected. The approach she uses is not an easy answer and it's not a guarantee. It involves a lot of capsules and big lifestyle changes. But for the right patient, it can be transforming. For more information about her work, please visit her website at www.drlindai.com/radical You can also listen to her interview on the Radical Remission podcast: https://www.podbean.com/ew/pb-7v5kr-1546ad9

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one. _____________   This Episode is also sponsored by Ryze Health Every minute counts in medicine—so why waste it on clunky admin work? With Ryze Health, practice management becomes effortless. Our all-in-one platform streamlines scheduling, patient communications, and insurance verification, giving you fewer no-shows, faster check-ins, and happier patients. Free yourself from paperwork and phone tag so you can focus on what truly matters: providing care. Visit http://ryzehealth.com/BootstrapMD today and see how simple running your practice can be. ______________ In this episode of BootstrapMD, Dr. Mike Woo-Ming opens up about the breaking point that forced him to ask for help. Bad location, useless equipment, $5,000 Valpak disasters, and exactly one patient looking for free advice  until one desperate phone call to a mentor turned everything around. From avoiding the crushing "stupid tax" and compressing years into months, to getting ruthless accountability, emotional support through the lows, real-world playbooks no CME ever teaches, instant network expansion, burnout prevention, borrowed confidence, and staying ethical while scaling — Mike proves mentorship isn't optional for physician entrepreneurs. It's the difference between surviving and thriving. If you've ever thought "I'm a doctor I should be able to figure this out alone," this episode is your wake-up call.   Three Actionable Takeaways: Stop paying the "stupid tax" on your own: Find a mentor who has already lost the money and time on the exact mistakes you're about to make — wrong EMRs, useless marketing agencies, bad locations and shortcut years of expensive trial-and-error in a single conversation. Make a list today of three physicians who are 2–5 years ahead of where you want to be: Reach out and book a paid 60-minute consultation, never ask for free advice. Respect their time, get laser-focused answers, and start implementing immediately. Audit your business honestly: if you got hit by a bus tomorrow, would it survive without you? Build systems, hire replaceable team members, cut clinical hours, and create a practice that serves your life instead of chaining you to it — that's the real freedom entrepreneurship promises.  About the Show: Bootstrap MD is the ultimate podcast for physician entrepreneurs looking to escape traditional healthcare and control their financial futures. Hosted by Dr. Mike Woo-Ming, a successful physician, entrepreneur, and investor, the show delivers actionable insights on starting businesses, creating passive income, and navigating healthcare entrepreneurship. Featuring interviews with industry leaders, physicians, and experts in telemedicine and digital health, it's your guide to building a profitable, fulfilling career.  Tune in weekly at  http://bootstrapmd.com     About the Host: Dr. Mike Woo-Ming has over 20 years of experience as a physician entrepreneur. He's built and sold multiple seven-figure companies and now leads Executive Medical, a group of clinics specializing in age management and aesthetics. Through BootstrapMD, he mentors physicians in business, content creation, and autonomy. Let's Connect: www.https://www.bootstrapmd.com   Want to start a podcast? Check out the Doctor Podcast Network!    

Financial planning expert Anjali Jariwala joins Tracy to discuss the unique financial challenges physician practice owners face and why comprehensive planning requires both personal wealth management and business strategy. With her background in tax and financial planning plus personal ties to the physician community, Anjali offers insider perspective on navigating the complex transition from residency to high earnings, building sustainable businesses, and creating alignment between personal values and professional goals.  Click here for full show notes  Is your practice growth-ready? See Where Your Practice Stands: Take our Practice Growth Readiness Assessment  Episode Highlights  The physician financial transition challenge: Why going from minimal resident income to high earnings overnight creates both financial and emotional complications that most physicians aren't trained to handle  Personal before business: Anjali's approach of spending 2-3 months on personal financial planning before touching business finances, and why this sequence creates better long-term alignment  Accountant vs. strategist: The critical distinction between historical accounting and forward-looking financial strategy—and why practice owners need both  Growth barriers decoded: How to recognize when your practice has hit a growth ceiling and what changes are typically needed to break through  The guilt factor: Why physician owners struggle with asking for help or outsourcing tasks, and how to reframe these decisions as strategic investments  Building your professional team: Beyond your clinical team, you need accountants, tax specialists, financial advisors, and attorneys—here's how to leverage them effectively  Know your numbers: Why practice owners must understand their books better than anyone else, even when outsourcing bookkeeping functions  Time as currency: Calculating your hourly rate and using it to make smarter decisions about which tasks to keep versus delegate  Memorable Quotes  "At the end of the day, money is a tool. We have emotions that get tied up in it, but we really need to unwind the emotion from the fact that this is just a tool."  "For many practice owners, your personal finances are so interconnected with the business that I want to have clarity on what you want to achieve personally. So then when I go into the business, we can align everything up to meet those goals."  "Part of it is identifying what are your strengths and where are your weaknesses, and then who are the people that you can plug in to help you with those weaknesses so it's not hindering your ability to grow."  "We spend so much time working in the business because we want to provide good care and take care of our clients and patients, that we don't focus enough time on working on the business."  "There's sometimes feelings of guilt to ask for help. Part of it is really coming at it from a standpoint of: I need help, it's okay to ask for help, and I shouldn't feel guilty about asking for this help because it's going to make my life better, my family's life better, and all the people who work for me better too."  Closing  Anjali's message about releasing the guilt around asking for help really resonates. As practice owners, we often carry this sense that we should be able to handle everything ourselves—but that mindset actually limits our growth and our impact. Whether it's financial planning, operations support, or strategic guidance, building the right team of trusted advisors isn't a weakness—it's how you create a practice that truly thrives.  Bio:  Anjali Jariwala is the founder of FIT Advisors, a financial planning firm serving physicians and business owners across the US. After working with Fortune 500 clients at distinguished firms, Anjali launched her own practice to help clients understand that money is a tool for reaching financial goals—while acknowledging how emotions impact financial decisions. Her expertise in tax and finance has been featured in CNBC, Bloomberg, The New York Times, USA Today, and Business Insider. Beyond financial planning, Anjali is also a children's book author. As a South Asian mom, she wrote Why We Eat With Our Hands to highlight day-to-day cultural traditions and increase representation for children who look like her daughter. Whether through financial advising or children's literature, Anjali is passionate about helping people feel empowered to build the lives they want.  Find Anjali:  Website  LinkedIn  Instagram  See Where Your Practice Stands: Take our Practice Growth Readiness Assessment  Connect With Us:  Be a Guest on the Show  Thriving Practice Community  Schedule Strategy Session with Tracy  Tracy's LinkedIn  Business LinkedIn Page 

Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, "Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas"  Host Dr. Rafeh Naqash and Drs. Ross and Cooper discuss the landscape of Delta-like ligand 3 (DLL3) and seizure-related homolog protein 6 (SEZ6) across NECs from eight different primary sites. TRANSCRIPT Dr. Rafeh Naqash: Hello and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCO PO articles. I'm your host, Dr. Rafeh Naqash, podcast editor for JCO PO and an Associate Professor at the OU Health Stephenson Cancer Center. Today, I'm excited to be joined by Dr. Jessica Ross, third-year medical oncology fellow at the Memorial Sloan Kettering Cancer Center, as well as Dr. Alissa Cooper, thoracic medical oncologist at the Dana-Farber Cancer Institute and instructor in medicine at Harvard Medical School. Both are first and last authors of the JCO Precision Oncology article entitled "Clinical and Pathologic Landscapes of Delta-like Ligand 3 and Seizure-Related Homolog Protein 6 or SEZ6 Protein Expression in Neuroendocrine Carcinomas." At the time of this recording, our guest disclosures will be linked in the transcript. Jessica and Alissa, welcome to our podcast, and thank you for joining us today. Dr. Jessica Ross: Thanks very much for having us. Dr. Alissa Cooper: Thank you. Excited to be here. Dr. Rafeh Naqash: It's interesting, a couple of days before I decided to choose this article, one of my GI oncology colleagues actually asked me two questions. He said, "Rafeh, do you know how you define DLL3 positivity? And what is the status of DLL3 positivity in GI cancers, GI neuroendocrine carcinomas?" The first thing I looked up was this JCO article from Martin Wermke. You might have seen it as well, on obrixtamig, a phase 1 study, a DLL3 bi-specific T-cell engager. And they had some definitions there, and then this article came along, and I was really excited that it kind of fell right in place of trying to understand the IHC landscape of two very interesting targets. Since we have a very broad and diverse audience, especially community oncologists, trainees, and of course academic clinicians and some people who are very interested in genomics, we'll try to make things easy to understand. So my first question for you, Jessica, is: what is DLL3 and SEZ6 and why are they important in neuroendocrine carcinomas? Dr. Jessica Ross: Yeah, good question. So, DLL3, or delta-like ligand 3, is a protein that is expressed preferentially on the tumor cell surface of neuroendocrine carcinomas as opposed to normal tissue. It is a downstream target of ASCL1, and it's involved in neuroendocrine differentiation, and it's an appealing drug target because it is preferentially expressed on tumor cell surfaces. And so, it's a protein, and there are several drugs in development targeting this protein, and then Tarlatamab is an approved bi-specific T-cell engager for the treatment of extensive-stage small cell lung cancer in the second line. SEZ6, or seizure-like homolog protein 6, is a protein also expressed on neuroendocrine carcinoma cell surface. Interestingly, so it's expressed on neuronal cells, but its exact role in neuroendocrine carcinomas and oncogenesis is actually pretty poorly understood, but it was identified as an appealing drug target because, similarly to DLL3, it's preferentially expressed on the tumor cell surface. And so this has also emerged as an appealing drug target, and there are drugs in development, including antibody-drug conjugates, targeting this protein for that reason. Dr. Alissa Cooper: Over the last 10 to 15 years or so, there's been an increasing focus on precision oncology, finding specific targets that actually drive the cancer to grow, not just within lung cancer but in multiple other primary cancers. But specifically, at least speaking from a thoracic oncology perspective, the field of non-small cell lung cancer has completely exploded over the past 15 years with the discovery of driver oncogenes and then matched targeted therapies. Within the field of neuroendocrine carcinomas, including small cell lung cancer but also other high-grade neuroendocrine carcinomas, there has not been the same sort of progress in terms of identifying targets with matched therapies. And up until recently, we've sort of been treating these neuroendocrine malignancies kind of as a monolithic disease process. And so recently, there's been sort of an explosion of research across the country and multiple laboratories, multiple people converging on the same open questions about why might patients with specific tumor biologies have different kind of responses to different therapies. And so first this came from, you know, why some patients might have a good response to chemo and immunotherapy, which is the first-line approved therapy for small cell lung cancer, and we also sort of extrapolate that to other high-grade neuroendocrine carcinomas. What's the characteristic of that tumor biology? And at the same time, what are other targets that might be identifiable? Just as Jesse was saying, they're expressed on the cell surface, they're not necessarily expressed in normal tissue. Might this be a strategy to sort of move forward and create smarter therapies for our patients and therefore move really into a personalized era for treatment for each patient? And that's really driving, I think, a lot of the synthesis of this work of not only the development of multiple new therapies, but really understanding which tumor might be the best fit for which therapy. Dr. Rafeh Naqash: Thank you for that explanation, Alissa. And as you mentioned, these are emerging targets, some more further along in the process with approved drugs, especially Tarlatamab. And obviously, DLL3 was something identified several years back, but drug development does take time, and readout for clinical trials takes time. Could you, for the sake of our audience, try to talk briefly about the excitement around Tarlatamab in small cell lung cancer, especially data that has led to the FDA approval in the last year, year and a half? Dr. Alissa Cooper: Sure. Yeah, it's really been an explosion of excitement over, as you're saying, the last couple of years, and work really led by our mentor, Charlie Rudin, had identified DLL3 as an exciting target for small cell lung cancer specifically but also potentially other high-grade neuroendocrine malignancies. Tarlatamab is a DLL3-targeting bi-specific T-cell engager, which targets DLL3 on the small cell lung cancer cells as well as CD3 on T cells. And the idea is to sort of introduce the cancer to the immune system, circumventing the need for MHC class antigen presentation, which that machinery is typically not functional in small cell lung cancer, and so really allowing for an immunomodulatory response, which had not really been possible for most patients with small cell lung cancer prior to this. Tarlatamab was tested in a phase 2 registrational trial of about 100 patients and demonstrated a response rate of 40%, which was very exciting, especially compared with other standard therapies which were available for small cell lung cancer, which are typically cytotoxic therapies. But most excitingly, more than even the response rate, I think, in our minds was the durability of response. So patients whose disease did have a response to Tarlatamab could potentially have a durable response lasting a number of months or even over a year, which had previously not ever been seen in this in the relapsed/refractory setting for these patients. I think the challenge with small cell lung cancer and other high-grade neuroendocrine malignancies is that a response to therapy might be a bit easier to achieve, but it's that durability. The patient's tumors really come roaring back quite aggressively pretty quickly. And so this was sort of the most exciting prospect is that durability of response, that long potential overall survival tail of the curve really being lifted up. And then most recently at ASCO this year, Dr. Rudin presented the phase 3 randomized controlled trial which compared Tarlatamab to physician's choice of chemotherapy in a global study. And the choice of chemotherapy did vary depending on the part of the world that the patients were enrolled in, but in general, it was a really markedly positive study for response rate, for progression-free survival, and for overall survival. Really exciting results which really cemented Tarlatamab's place as the standard second-line therapy for patients with small cell lung cancer whose disease has progressed on first-line chemo-immunotherapy. So that has been very exciting. This drug was FDA approved in May of 2024, and so has been used extensively since then. I think the adoption has been pretty widespread, at least in the US, but now in this global trial that was just presented, and there was a corresponding New England Journal paper, I think really confirms that this is something we really hopefully can offer to most of our patients. And I think, as we all know, that this therapy or other therapies like it are also being tested potentially in the first-line setting. So there was data presented with Tarlatamab incorporated into the maintenance setting, which also showed exciting results, albeit in a phase 1 trial, but longer overall survival than we're used to seeing in this patient population. And we await results of the study that is incorporating Tarlatamab into the induction phase with chemotherapy as well. So all of this is extraordinarily exciting for our patients to sort of move the needle of how many patients we can keep alive, feeling functional, feeling well, for as long as possible. Dr. Rafeh Naqash: Very exciting session at ASCO. I was luckily one of the co-chairs for the session that Dr. Rudin presented it, and I remember somebody mentioning there was more progress seen in that session for small cell lung cancer than the last 30, 35 years for small cell, very exciting space and time to be in as far as small cell lung cancer. Now going to this project, Jessica, since you're the first author and Alissa's the last, I'm assuming there was a background conversation that you had with Alissa before you embarked on this project as an idea. So could you, again, for other trainees who are interested in doing research, and it's never easy to do research as a resident and a fellow when you have certain added responsibilities. Could you give us a little bit of a background on how this started and why you wanted to look at this question? Dr. Jessica Ross: Yeah, sure. So, as with many exciting research concepts, I think a lot of them are derived from the clinic. And so I think Alissa and I both see a good number of patients with small cell, large cell lung cancer, and then high-grade neuroendocrine carcinomas. And so I think this was really born out of a basic conversation of we have these drugs in development targeting these two proteins, DLL3 and SEZ6, but really what is the landscape of cancers that express these proteins and who are the patients that really might benefit from these exciting new therapies. And of course, there was some data out there, but sort of less than one would imagine in terms of, you know, neuroendocrine carcinomas can really come from anywhere in the body. And so when you're seeing a patient with small cell of the cervix, for example, like what are the chances that their cancer expresses DLL3 or expresses SEZ6? So it was really derived from this pragmatic, clinically oriented question that we had both found ourselves thinking about, and we were lucky enough at MSK, we had started systematically staining patients' tumors for DLL3, tumors that are high-grade neuroendocrine carcinomas, and then we had also more recently started staining for SEZ6 as well. And so we had this nice prospectively collected dataset with which to answer this question. Dr. Rafeh Naqash: Excellent. And Alissa, could you try to go into some of the details around which patients you chose, how many patients, what was the approach that you selected to collect the data for this project? Dr. Alissa Cooper: This is perhaps a strength but also maybe a limitation of this dataset is, as Jesse alluded to, our pathology colleagues are really the stars of this paper here because we were lucky enough at MSK that they were really forethinking. They are absolute experts in the field and really forward-thinking people in terms of what information might be needed in the future to drive treatment decision-making. And so, as Jesse had said, small cell lung cancer tumor samples reflexively are stained for DLL3 and SEZ6 at MSK if there's enough tumor tissue. The other high-grade neuroendocrine carcinomas, those stains are performed upon physician request. And so that is a bit of a mixed bag in terms of the tumor samples we were able to include in this dataset because, you know, upon physician request depends on a number of factors, but actually at MSK, a number of physicians were requesting these stains to be done on their patients with high-grade neuroendocrine cancers of of other histologies. So we looked at all tumor samples with a diagnosis of high-grade neuroendocrine carcinoma of any histology that were stained for these two stains of interest. You know, I can let Jesse talk a bit more about the methodology. She was really the driver of this project. Dr. Jessica Ross: Yeah, sure. So we had 124 tumor samples total. All of those were stained for DLL3, and then a little less than half, 53, were stained for SEZ6. As Alissa said, they were from any primary site. So about half of them were of lung origin, that was the most common primary site, but we included GI tract, head and neck, GU, GYN, even a few tumors of unknown origin. And again, that's because I think a lot of these trials are basket trials that are including different high-grade neuroendocrine carcinomas no matter the primary site. And so we really felt like it was important to be more comprehensive and inclusive in this study. And then, methodologically, we also defined positivity in terms of staining of these two proteins as anything greater than or equal to 1% staining. There's really not a defined consensus of positivity when it comes to these two novel targets and staining for these two proteins. But in the Tarlatamab trials, for some of the correlative work that's been done, they use that 1% cutoff, and we just felt like being consistent with that and also using a sort of more pragmatic yes/no cutoff would be more helpful for this analysis. Dr. Alissa Cooper: And that was a point of discussion, actually. We had contemplated multiple different schemas, actually, for how to define thresholds of positivity. And I know you brought up that question before, what does it mean to be DLL3 positive or DLL3 high? I think you were alluding to prior that there was a presentation of obrixtamig looking at extra-pulmonary neuroendocrine carcinomas, and they actually divvied up the results between DLL3 50% or greater versus DLL3 low under 50%. And they actually did demonstrate differential efficacy certainly, but also some differential safety as well, which is very provocative and that kind of analysis has not been presented for other novel therapies as far as I'm aware. I could be wrong, but as far as I'm aware, that was sort of the first time that we saw a systematic presentation of considering patients to be, quote unquote, "high" or "low" in these sort of novel targets. I think it is important because the label for Tarlatamab does not require any DLL3 expression at all, actually. So it's not hinging upon DLL3 expression. They depend on the fact that the vast majority of small cell lung cancer tumors do express DLL3, 85% to 90% is what's been demonstrated in a few studies. And so, there's not prerequisite testing needed in that regard, but maybe for these extra-pulmonary, other histology neuroendocrine carcinomas, maybe it does matter to some degree. Dr. Rafeh Naqash: Definitely agree that this evolving landscape of trying to understand whether an expression for something actually really does correlate with, whether it's an immune cell engager or an antibody-drug conjugate is a very evolving and dynamically moving space. And one of the questions that I was discussing with one of my friends was whether IHC positivity and the level of IHC positivity, as you've shown in one of those plots where you have double positive here on the right upper corner, you have the double negative towards the left lower, whether that somehow determines mRNA expression for DLL3. Obviously, that was not the question here that you were looking at, but it does kind of bring into question certain other aspects of correlations, expression versus IHC. Now going to the figures in this manuscript, very nicely done figures, very easy to understand because I've done the podcast for quite a bit now, and usually what I try to do first is go through the figures before I read the text, and and a lot of times it's hard to understand the figures without reading the text, but in your case, specifically the figures were very, very well done. Could you give us an overview, a quick overview of some of the important results, Jessica, as far as what you've highlighted in the manuscript? Dr. Jessica Ross: Sure. So I think the key takeaway is that, of the tumors in our cohort, the majority were positive for DLL3 and positive for SEZ6. So about 80% of them were positive for DLL3 and 80% were positive for SEZ6. About half of the tumors were stained for both proteins, and about 65% of those were positive as well. So I think if there's sort of one major takeaway, it's that when you're seeing a patient with a high-grade neuroendocrine carcinoma, the odds are that their tumor will express both of these proteins. And so that can sort of get your head thinking about what therapies they might be eligible for. And then we also did an analysis of some populations of interest. So for example, we know that non-neuroendocrine pathologies can transform into neuroendocrine tumors. And so we specifically looked at that subset of patients with transformed tumors, and those were also- the majority of them were positive, about three-quarters of them were positive for both of these two proteins. We looked at patients with brain met samples, again, about 70% were positive. And then I'd say the last sort of population of interest was we had a subset of 10 patients who had serial biopsies stained for either DLL3 or SEZ6 or both. In between the two samples, these patients were treated with chemotherapy. They were not treated with targeted therapy, but interestingly, in the majority of cases, the testing results were concordant, meaning if it was DLL3 positive to begin with, it tended to remain DLL3 positive after treatment. And so I think that's important as well as we think about, you know, a patient who maybe had DLL3 testing done before they received their induction chemo-IO, we can somewhat confidently say that they're probably still DLL3 positive after that treatment. And then finally, we did do a survival analysis among specifically the patients with lung neuroendocrine carcinomas. We looked at whether DLL3 expression affected progression-free survival on first-line platinum-etoposide, and then we looked at did it affect overall survival. And we found that it did not have an impact or the median progression-free survival was similar whether you were DLL3 positive or negative. But interestingly, with overall survival, we found that DLL3 positivity actually correlated with slightly improved overall survival. These were small numbers, and so, you know, I think we have to interpret this with caution, for sure, but it is interesting. I think there may be something to the fact that five of the patients who were DLL3 positive were treated with DLL3-targeting treatments. And so this made me think of, like in the breast cancer world, for example, if you have a patient with HER2-positive disease, it initially portended worse prognosis, more aggressive disease biology, but on the other hand, it opens the door for targeted treatments that actually now, at least with HER2-positive breast cancer, are associated with improved outcomes. And so I think that's one finding of interest as well. Dr. Rafeh Naqash: Definitely proof-of-concept findings here that you guys have in the manuscript. Alissa, if I may ask you, what is the next important step for a project like this in your mind? Dr. Alissa Cooper: Jesse has highlighted a couple of key findings that we hope to move forward with future investigative studies, not necessarily in a real-world setting, but maybe even in clinical trial settings or in collaboration with sponsors. Are these biomarkers predictive? Are they prognostic? You know, those are still- we have some nascent data, data has been brewing, but I think that we we still don't have the answers to those open questions, which I think are critically important for determining not only clinical treatment decision-making, but also our ability to understand sequencing of therapies, prioritization of therapies. I think a prospective, forward-looking project, piggybacking on that paired biopsy, you know, we had a very small subset of patients with paired biopsies, but a larger subset or cohort looking at paired biopsies where we can see is there evolution of these IHC expression, even mRNA expression, as you're saying, is there differential there? Are there selection pressures to targeted therapies? Is there upregulation or downregulation of targets in response not just to chemotherapy, but for example, for other sort of ADCs or bi-specific T-cell engagers? I think those are going to be critically important future studies which are going to be a bit challenging to do, but really important to figure out this key clinical question of sequencing, which we're all contemplating in our clinics day in and day out. If you have a patient, and these patients often can be sick quite quickly, they might have one shot of what's the next treatment that you're going to pick. We can't guarantee that every patient is going to get to see every therapy. How can you help to sort of answer the question of like what should you offer? So I think that's the key question sort of underlying any future work is how predictive or prognostic are these biomarkers? What translational or correlative studies can we do on the tissue to understand clinical treatment decision-making? I think those are the key things that will unfold in the next couple of years. Dr. Rafeh Naqash: The last question for you, Alissa, that I have is, you are fairly early in your career, and you've accomplished quite a lot. One of the most important things that comes out from this manuscript is your mentorship for somebody who is a fellow and who led this project. For other junior investigators, early-career investigators, how did you do this? How did you manage to do this, and how did you mentor Jessica on this project with some of the lessons that you learned along the way, the good and other things that would perhaps help other listeners as they try to mentor residents, trainees, which is one of the important things of what we do in our daily routine? Dr. Alissa Cooper: I appreciate you calling me accomplished. Um, I'm not sure how true that is, but I appreciate that. I didn't have to do a whole lot with this project because Jesse is an extraordinarily smart, driven, talented fellow who came up with a lot of the clinical questions and a lot of the research questions as well. And so this project was definitely a collaborative project on both of our ends. But I think what was helpful from both of our perspectives is from my perspective, I could kind of see that this was a gap in the literature that really, I think, from my work leading clinical trials and from treating patients with these kinds of cancers that I really hoped to answer. And so when I came to Jessica with this idea as sort of a project to complete, she was very eager to take it and run with it and also make it her own. You know, in terms of early mentorship, I have to admit this was the first project that I mentored, so it was a great learning experience for me as well because as an early-career clinician and researcher, you're used to having someone else looking over your shoulder to tell you, "Yes, this is a good journal target, here's what we can anticipate reviewers are going to say, here are other key collaborators we should include." Those kind of things about a project that don't always occur to you as you're sort of first starting out. And so all of that experience for me to be identifying those more upper-level management sort of questions was a really good learning experience for me. And of course, I was fantastically lucky to have a partner in Jesse, who is just a rising star. Dr. Jessica Ross: Thank you. Dr. Rafeh Naqash: Well, excellent. It sounds like the first of many other mentorship opportunities to come for you, Alissa. And Jessica, congratulations on your next step of joining and being faculty, hopefully, where you're training. Thank you again, both of you. This was very insightful. I definitely learned a lot after I reviewed the manuscript and read the manuscript. Hopefully, our listeners will feel the same. Perhaps we'll have more of your work being published in JCO PO subsequently. Dr. Alissa Cooper: Hope so. Thank you very much for the opportunity to chat today. Dr. Jessica Ross: Yes, thank you. This was great. Dr. Rafeh Naqash: Thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review and be sure to subscribe so as you never miss an episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Disclosures: Dr. Alissa Jamie Cooper Honoraria Company: MJH Life Scienes, Ideology Health, Intellisphere LLC, MedStar Health, Physician's Education Resource, LLC,  Gilead Sciences, Regeneron, Daiichi Sankyo/Astra Zeneca, Novartis,  Research Funding: Merck, Roche, Monte Rosa Therapeutics, Abbvie, Amgen, Daiichi Sankyo/Astra Zeneca Travel, Accommodations, Expenses: Gilead Sciences

Much like any other industry (with the hopeful exception of airline pilots) there are great individuals and not so great ones. Physicians are no different and in today's episode, we're going to explore 5 red flags that signal it may be time to find another doctor. From not feeling seen and heard to being trigger happy with the prescription pad, these key points are important for your short and long term health. Topics include: - 5 Signs You May Need to Change Physicians- The Reality of Doctors In Our Modern Insurance Ecosystem- How Functional Health Came to the Forefront- Chris Rock Quote on Pilots- Don't Feel Heard or Deny Your Self-Advocacy- A Lot Of Doctors Want Proactive Patients- The Good to Bad Spectrum- Trigger Finger With The Prescription Pad- Statin Drugs As An Example- Quoting Outdated Information- Not Open to New Evidence---------- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Live Program for Coaches: The Functional Nutrition and Metabolism Specialization ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.metabolismschool.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---------- [Free] Metabolism School 101: The Video Series⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.metabolismschool.com/metabolism-101⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------Subscribe to My Youtube Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://youtube.com/@sammillerscience?si=s1jcR6Im4GDHbw_1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Grab a Copy of My New Book - Metabolism Made Simple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠---------- Stay Connected: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: @sammillerscience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube: SamMillerScience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: The Nutrition Coaching Collaborative Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok: @sammillerscience⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠----------“This Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast and the show notes or the reliance on the information provided is to be done at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for educational purposes only. Always consult your physician before beginning any exercise program and users should not disregard, or delay in obtaining, medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. By accessing this Podcast, the listener acknowledges that the entire contents and design of this Podcast, are the property of Oracle Athletic Science LLC, or used by Oracle Athletic Science LLC with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, retransmission or editing, of this Podcast may be made without the prior written permission of Oracle Athletic Science LLC, which may be requested by contacting the Oracle Athletic Science LLC by email at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠operations⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@sammillerscience.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. By accessing this Podcast, the listener acknowledges that Oracle Athletic Science LLC makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast."

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.___________________ Ever wonder why success doesn't feel successful?You've checked every box — med school, residency, family, stability — yet still feel that quiet tug of restlessness. Dr. Richard Boyatzis, joins Dr. Bradley Block to unpack why even accomplished physicians often lose their sense of meaning mid-career. Drawing from his Intentional Change Theory, Dr. Boyatzis explains that fulfillment dips every 7–10 years as part of our natural life cycle — what he calls liminality, the space between “what was” and “what's next.” The fix isn't distraction (real estate, side gigs, or skydiving), but rediscovering your vision — your “ideal self” — and aligning daily work with your true values.He warns against the trap of coaching for compliance — trying to fix patients (or yourself) through fear and goals. Instead, focus on coaching with compassion — inspiring sustained change through purpose, gratitude, and hope. Physicians, he says, thrive when they reconnect to why they entered medicine: to help, heal, and matter. Through personal stories, neuroscience, and humor, Dr. Boyatzis offers a practical roadmap for reigniting passion without abandoning your profession — whether that means teaching, mentoring, volunteering, or simply reframing success through renewed purpose.Three Actionable Takeaways:Revisit Your Vision Every 7–10 Years:  Midlife restlessness isn't failure — it's biology. Reflect on your ideal self by asking, “If my life were fantastic 10–15 years from now, what would it look like?” Write it down, talk it out, and use it to guide new choices in work and life.Coach (and Care) with Compassion, Not Compliance: Patients — and physicians — change through hope, not fear. Replace “If you don't…” warnings with vision-driven goals (“What do you want to live for?”). Shared purpose boosts motivation, treatment adherence, and well-being.Recharge with Purposeful Connection: Gratitude and positive storytelling aren't fluff — they activate the parasympathetic system and restore energy. Start meetings or days with one uplifting story, or jot three things you're grateful for. It rewires stress into meaning. About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!Dr. Richard Boyatzis is a Distinguished University Professor at Case Western Reserve University and one of the world's most cited scholars on emotional intelligence, leadership, and behavior change. Co-author of Primal Leadership and Helping People Change, his latest book, The Science of Change, distills decades of research into how individuals and organizations achieve sustained transformation. A global consultant and teacher, his work has reached over 1.5 million learners worldwide.LinkedIn: https://www.linkedin.com/in/richard-boyatzis-401822a Website: case.eduAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In the third episode of our upper extremity spasticity series, host Paul Wirkus, MD, FAAP and Shawn Mendenhall, MD focus on what success truly looks like - both in the short term and long term. Our guests discuss how to measure meaningful outcomes for children, from functional gains to improved comfort and participation in daily activities. We also look ahead to the future of spasticity care, exploring emerging approaches, evolving surgical techniques, and innovations that may improve assessment and treatment. Together, the conversation highlights the importance of individualized goals, interdisciplinary follow-through, and continuous reevaluation to ensure each child progresses toward their highest potential. Have a question? Email questions@vcurb.com. They will be answered next week.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

We're re-releasing one of our most popular episodes, an important conversation with Wolfram syndrome expert Dr. Fumi Urano.   We're bringing this episode back in honor of Diabetic Eye Disease Month, and because it's the perfect follow-up to our last episode featuring Dr. Rachel Hyman and our very own co-host Cathy Gildenhorn as guests. Their experiences with the milder, adult-onset variant of Wolfram syndrome sparked so much interest, we knew this episode needed another moment in the spotlight. You'll hear Cathy interview Dr. Urano, her lead physician, about symptoms, diagnosis, and promising research underway to help people with rare neurodegenerative disorders like Wolfram syndrome.   We are thrilled to have Dr. Fumihiko Urano on “It Happened To Me” as he is our co-host Cathy's lead doctor, for her variant of the rare disease, Wolfram Syndrome.    Fumihiko “Fumi” Urano, MD, Ph.D., is a Physician and Medical Researcher specializing in Wolfram syndrome, characterized by juvenile-onset diabetes, vision loss, and neurodegeneration. Dr. Urano is a Professor of Medicine and Pathology & Immunology, an attending physician at Endocrinology Genetics Clinic, and currently holds Samuel E. Schechter Endowed Professorship in Medicine at Washington University Medical Center, St. Louis, USA. Dr. Urano is a driving force in the study of Wolfram syndrome and Related Disorders, including WFS1-related disorders/Wolfram-like disorders. As the Director of the Wolfram Syndrome and Related Disorders Clinic and Study at Washington University Medical Center, Dr. Urano has been leading the clinical, translational, and interventional studies of Wolfram syndrome and Related disorders. Dr. Urano's collaboration with colleagues at the medical center and around the world has allowed him to develop cutting-edge treatments for this disease, including gene therapy and regenerative therapy.    Learn more on their Wolfram syndrome website, wolframsyndrome.wustl.edu. If you want to reach out directly you can contact the Research Nurse Coordinator Stacy Hurst, RN, CDE by calling 314-747-3294 or emailing shurst@wustl.edu.    During the episode Dr. Urano mentioned two episodes of “It Happened To Me”: during this episode. The first was our interview with Dr. Gladstone in Episode 5. He also gave a shoutout to our conversation with Stephanie Snow Gebel (Snow Foundation) in Episode 9.    Stay tuned for the next new episode of “It Happened To Me”! In the meantime, you can listen to our previous episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “It Happened To Me”.    “It Happened To Me” is created and hosted by Cathy Gildenhorn and Beth Glassman. DNA Today's Kira Dineen is our executive producer and marketing lead. Amanda Andreoli is our associate producer. Ashlyn Enokian is our graphic designer.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, ItHappenedToMePod.com. Questions/inquiries can be sent to ItHappenedToMePod@gmail.com.

Innovative Approaches to Pediatric Neurodevelopmental ScreeningIn this episode of The Pediatric Lounge, the hosts interview Dr. Susan Gunduz, an independent pediatrician and founder of Northport Pediatrics. Dr. Gunduz discusses her innovative program, 'Sound Wise for Kids,' which is designed to identify developmental delays in children aged three to nine through interactive assessments. She elaborates on the importance of early detection and intervention for developmental challenges and shares her vision of digitizing the program to make it scalable and accessible to a wider audience. The conversation also touches upon the barriers to early intervention, the use of AI in medicine, and the future of personalized care in pediatrics. The discussion highlights the need for pediatricians to lead the way in developmental health and education to ensure children's successful academic and personal development.00:00 Introduction to The Pediatric Lounge00:43 Meet Dr. Susan Gunn: Pediatrician and Innovator03:01 The Journey to Pediatric Medicine03:57 Identifying Developmental Delays05:09 Interactive Assessments in Pediatric Care07:14 Challenges and Innovations in Early Intervention08:09 The Role of Technology in Pediatric Assessments14:42 Barriers to Early Intervention Services25:36 The Importance of Pediatric Development28:11 The Future of Pediatric Care and Education31:55 Addressing Childhood Obesity32:26 The Importance of Early Education34:10 Challenges in Academic Medicine35:27 Funding and Innovation in Pediatrics41:10 Silicon Valley and Medical Technology45:16 The Future of Predictive Medicine48:24 AI in Medical Documentation58:49 Closing Remarks and Final ThoughtsSupport the show

Dr. Greg Hammer, is a Former Professor at Stanford University School of Medicine, Physician, Best-Selling Author, and Mindfulness Expert.It was a wonderful conversation as he shared stories of his grandmother and her love for art and he declaration about using proper english grammar. Greg shares how he inherited  that same consciousness as to being respectful to the english language.A Best Selling Author with an eye on being active and healthy, his recent book is about adults, caregivers, teachers helping teenagers reduce their stress levels by using his meditative technique incorporating Gratitude, Acceptance, Intention and Non judgement in a 3-4 minute daily meditation that anyone can do. He explains and walks us through a short meditation during this conversation.It's important for all of us to have balance in our lives-mental and physical balance and peace.It was a real pleasure speaking and meeting Dr. Greg Hammer.architectInformation about his most recent book: A Mindful Teen: Helping Today's Teenagers Thrive through Gratitude, Acceptance, Intention, and Non judgement Topic: Coping Strategies for Youth this National Suicide Prevention MonthTalk Points: Destigmatization is the key - Suicide is preventable through awareness, education, and accessible resources.The more we discuss mental health in productive ways, the better primed we will be to catch the warning signs before they progress into something serious.Openly discussing mental health encourages youth to initiate those conversations for themselves and ask for help should they need it.Today's teens face stressors that older generations never imaginedSocial media, smartphones, and the internet – and AIAfter-effects of COVID lockdown and isolationThe great political divide, affecting relationships in and outside of familiesIncreasingly competitive college admission and tuitionThe economic pressures their families faceThe Role of Parents and Parenting  - Cultivating Compassion, Forgiveness, and EmpathyThe Risks and How to Spot Them*Early Detection can save your child's life - The warning signs that someone is struggling with their mental health can easily be overlooked (especially amongst teenagers).*The most common symptoms of depression and anxiety (i.e. changes in behavior and mood, irritability, changes in sleep habits, changes in eating habits, withdrawing socially) are also commonly associated with the standard growing pains and hormonal shifts of adolescence. So, how do you know the difference?If something feels off with your child, the best thing you can do is ask.Sit down with your child and have a gentle, but honest conversation about your concerns. You may have to speak with them multiple times before they're ready to open up. Trust your instincts and be gently persistent.Consult a Mental Health Professional: There is no shame in asking for help for both teens and adults.Mindfulness at Home - Encouraging children to practice mindfulness daily can help build their mental and emotional resilience and protect their mental health in the short and long term.*Mindfulness can be a great tool to help teens rewire their brains away from the negativity on which they dwell. It can neutralize their tendency to ruminate over the past, often leading to depression, and to overthinking the future, creating fear and anxiety.The GAIN Method - Gratitude, Acceptance, Intention, and Nonjudgment are the pillars of happiness for teens - and for the rest of us.Website:https://amindfulteen.com/Facebook: @GregHammerMD; https://www.facebook.com/greghammermd/Instagram: @greghammermd; https://www.instagram.com/greghammermd/LinkedIn:https://www.linkedin.com/in/greg-hammer-02b20422/ "Should Have Listened To My Mother" is an ongoing conversation about mothers/female role models and the roles they play in our lives. Jackie's guests are open and honest and answer the question, are you who you are today because of, or in spite of, your mother and so much more. You'll be amazed at what the responses are.Gina Kunadian wrote this 5 Star review on Apple Podcast:SHLTMM TESTIMONIAL GINA KUNADIAN JUNE 18, 2024“A Heartfelt and Insightful Exploration of Maternal Love”Jackie Tantillo's “Should Have Listened To My Mother” Podcast is a treasure and it's clear why it's a 2023 People's Choice Podcast Award Nominee. This show delves into the profound impact mother and maternal role models have on our lives through personal stories and reflections.Each episode offers a chance to learn how different individuals have been shaped by their mothers' actions and words. Jackie skillfully guides these conversations, revealing why guests with similar backgrounds have forged different paths.This podcast is a collection of timeless stories that highlight the powerful role of maternal figures in our society. Whether your mother influenced you positively or you thrived despite challenges, this show resonates deeply.I highly recommend “Should Have Listened To My Mother” Podcast for its insightful, heartfelt and enriching content.Gina Kunadian"Should Have Listened To My Mother" would not be possible without the generosity, sincerity and insight from my guests. In 2018/2019, in getting ready to launch my podcast, so many were willing to give their time and share their personal stories of their relationship with their mother, for better or worse and what they learned from that maternal relationship. Some of my guests include Nationally and Internationally recognized authors, Journalists, Columbia University Professors, Health Practitioners, Scientists, Artists, Attorneys, Baritone Singer, Pulitzer Prize Winning Journalist, Activists, Freighter Sea Captain, Film Production Manager, Professor of Writing Montclair State University, Attorney and family advocate @CUNY Law; NYC First Responder/NYC Firefighter, Child and Adult Special Needs Activist, Property Manager, Chefs, Self Help Advocates, therapists and so many more talented and insightful women and men.Jackie has worked in the broadcasting industry for over four decades. She has interviewed many fascinating people including musicians, celebrities, authors, activists, entrepreneurs, politicians and more.A big thank you goes to Ricky Soto, NYC based Graphic Designer, who created the logo for "Should Have Listened To My Mother".Check out the SHLTMM Podcast website for more background information: https://www.jackietantillo.com/Or more demos of what's to come at https://soundcloud.com/jackie-tantilloLink to website and show notes: https://shltmm.simplecast.com/Or Find SHLTMM Website here: https://shltmm.simplecast.com/Listen wherever you find podcasts: https://www.facebook.com/ShouldHaveListenedToMyMotherhttps://www.facebook.com/jackietantilloInstagram:https://www.instagram.com/shouldhavelistenedtomymother/https://www.instagram.com/jackietantillo7/LinkedIn:https://www.linkedin.com/in/jackie-tantillo/YOUTUBE: https://www.youtube.com/@ShouldHaveListenedToMyMother

Send us a textWe're kicking off Season 4 of the Medical Money Matters Podcast, and we're celebrating something big. Over 10,000 downloads. Listeners tuning in from nearly 1,000 cities across the country—and even internationally. And we're entering our fourth year of episodes. Honestly, that number still stuns me a little. When we launched this podcast, our goal was simple: to help physicians and practice leaders navigate the business of medicine without losing sight of why they went into medicine in the first place.We wanted to demystify the money side. To have honest, clear conversations about things like revenue cycle, financial strategy, payer policies, and practice independence. We believed then—and we still do now—that when doctors understand the financial side of their practice, they're better equipped to lead, grow, and stay independent.And we're just getting started.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-business-finance-in-your-medical-practice/ Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

A growing number of US states and other nations are legalizing either voluntary euthanasia in which a physician (or designate) administers lethal drugs, or physician-assisted dying in which the drugs are given to the patient to self-administer. Our guest, Erica Baccus, tells us about her husband's determination to end his life rather than die of Alzheimer's disease, and the journey they took to Switzerland to make it possible (US laws don't apply to dementia).  His wishes were unquestionably honored. At the same time the procedure has implications we find troubling, especially for what it can mean for the doctor-patient relationship, such as in Canada where some physicians are now killing several of their patients a week.

On this date in 1932, a two-day demonstration of Boy Scout activities was held at the Wahpeton Indian School for troops from Richland and Wilkin counties. Physician and author Charles Alexander Eastman, a Sisseton-Wahpeton Dakota, served as an advisor in developing the national Boy Scout movement and its Native American Lore component.

Send us a textYou don't have “insomnia.”You have too much on your mind, too much on your plate, and a healthcare system that treats your sleep like an optional hobby.In this episode of Ending Physician Overwhelm, we're diving into sleep as a radical act of self-preservation for physicians. This is Week 4 of the 10-Week Recharge Challenge, and we're getting honest about why you're not sleeping—and what you can actually do about it.We'll talk about:

Why the rates of mental health challenges are so high among physicians. A UW professor collaborated with Bad Bunny on his award-winning album. A local artist who paints signs you'll recognize from around Milwaukee.

Informed Dissent with Dr. Jeff Barke and Dr. Mark McDonald – A therapist challenges current trends in youth gender medicine, stressing honesty, holistic care, and family involvement. Physicians warn about rapid medicalization and urge careful evaluation. The piece emphasizes protecting children through truth, thoughtful therapy, and courage from parents, clinicians, and communities committed to their wellbeing...

Certified financial planner Paul Morton discusses his article "Physician practice ownership: risks, rewards, and reality." Paul breaks down the massive differences between an employed physician's financial journey and that of an equity owner physician, exploring the reasons doctors choose the high-risk, high-reward path of private practice: the desire for control over patient culture, the "visionary" mindset, and the potential for a nonlinear financial reward. Paul dives into the challenging realities of managing overhead, dealing with inconsistent income from reimbursements, and the critical importance of strategic tax planning. This episode is a must-listen for any physician weighing the risks of entrepreneurship against the massive potential payoff of a "liquidity event." Learn the financial strategies that separate struggling practice owners from the highly successful ones. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Informed Dissent with Dr. Jeff Barke and Dr. Mark McDonald – A therapist challenges current trends in youth gender medicine, stressing honesty, holistic care, and family involvement. Physicians warn about rapid medicalization and urge careful evaluation. The piece emphasizes protecting children through truth, thoughtful therapy, and courage from parents, clinicians, and communities committed to their wellbeing...

Rick Allen was raised in an Irish-Catholic family, but he made his profession of faith some time after graduating college. From there, his journey of faith and his career path progressed side-by-side. Over time, Rick went from volunteering at church to pastoring a church plant, and from software salesman to CEO of a development company. Then with his ministry experience and leadership skills, Rick transitioned to become president and CEO of MedSend, an organization that has mobilized over 750 Christ-following, disciple-making healthcare professionals into 103 nations.   MedSend doesn't just send doctors overseas, it helps train native physicians to care and witness within their own communities. Under Rick's leadership, MedSend's National Scholars Pathway is equipping African, Asian, and Middle Eastern doctors with advanced medical and biblical training so that they can heal physically and introduce people to Jesus right where they live. Rick is passionate about seeing nations transformed with the love of God through well-equipped, Christ-following medical professionals. Millions of lives have already been touched, and MedSend has a vision to reach millions more with fully equipped Christ-centered hospital systems and networks. If you want to learn how faith, medicine, and missions can fuse in sustainable ways, this episode is for you.   Major Topics Include: Learning to trust God when you can't see what's ahead The desperate need for well-trained health care professionals globally Raising up medical professionals to minister to their own people ROI of investing in a national missionary physician Training medical professionals to share the gospel and disciple others Extending impact through partnership Helping medical missionaries care for themselves through the longevity program MedSend's long-term goal to transform nations through hospital systems and networks QUOTES TO REMEMBER “And I knew immediately that I wasn't trusting God.” “What does it look like for a Christ-following man to trust and surrender?” “I got to see God at work across the table and across the world, and it transformed my understanding of who God is.” “If you approach God with an open mind and and open heart and say, ‘if you're real, show me,' God will show up every time.” “These individuals are taking the love of Christ and a vision for compassionate care into their own healthcare systems and transforming them in the love of Christ.” “We anticipate that an individual physician will touch about 100,000 lives during their career. So we're training up people that will bless and share the knowledge of Christ with 100,000 people in a lifetime. That level of investment pays off over decades.”  “This is not about building healthcare capacity. This is about building Christ-followers who see healthcare as a means to share the love of Jesus Christ.” LINKS FROM THE SHOW MedSend Institute of Global Healthcare Missions Christian Medical & Dental Associations Samaritan's Purse ROI Ministry (see our interview with founder, Tim Barker) The Finish Line Community Facebook Group The Finish Line Community LinkedIn Group WE WANT TO HEAR FROM YOU! If you have a thought about something you heard, or a story to share, please reach out! You can find us on Instagram, Facebook, and LinkedIn. You can also contact us directly from our contact page. If you want to engage with the Finish Line Community, check out our groups on Facebookand LinkedIn.

Ever feel like you're running on empty as the year wraps up? You're not alone—and here's why I'm hitting pause.In this behind-the-scenes episode, I share the real reason I'm stepping back temporarily from the Independent Physician's Podcast, how the end-of-year medical practice duties are impacting even the most experienced physicians, and why this strategic recharge is key—not just for me, but also for you.Hear how I'm managing Medicare Advantage madness and practice stress behind the scenesGet a sneak peek at the powerful video episode dropping soon with a returning guest and new voice - (so excited to release this soon)Learn what to expect from the podcast as we head into 2026 with fresh clarity and purposeHit play now to hear why stepping back is part of moving forward—and what's coming next for independent-minded physicians like you.TEXT HERE on your Phone's Podcast App Discover how medical graduates, junior doctors, and young physicians can navigate residency training programs, surgical residency, and locum tenens to increase income, enjoy independent practice, decrease stress, achieve financial freedom, and retire early, while maintaining patient satisfaction and exploring physician side gigs to tackle medical school loans.

Comprehensive coverage of the day's news with a focus on war and peace; social, environmental and economic justice. Foto: Jonas Pereira/Agência Senado UN Security Council passes Gaza peace with “Board of Peace” headed by Trump; COP 30 Climate Summit hears small island nation calls for stronger action on global warming; Weekend immigration raids in Charlotte NC trigger protests over aggressive tactics; Judge injunction blasts Trump cuts to university research funding, as critics say universities capitulating to Trump; Palestinian deaths in Israeli jails surged during Gaza war, according to Physicians for Human Rights Israel; UN marks anniversary of Srebenica Genocide at new memorial, reminder of 1995 massacre and UN's failure to stop it; Greece marks anniversary of 1973 student uprising against US-backed military dictatorship The post UN Security Council passes Gaza peace resolution; COP 30 Climate Summit hears small island nation calls for stronger action – November 17, 2025 appeared first on KPFA.

Alex Giorgetti is a celebrated professional water polo World Champion, Olympic Silver Medalist and owner of a non-profit organization, Giorgetti Athletics where his goal it to build next generation champions ready to earn top scholarships in best U.S. universities or reach professional water polo leagues across Europe. He was a guest keynote speaker at the 4th annual Medical Innovation Olympics where he shared vivid lessons from Olympics and World Championships on maintaining a resilient mindset, the power of generating strong unity and habits in teams, Medical Innovations in analytics to personalize training to a given player or position, and tangible lessons to build winning teams in business.0:00 Team Sport is like an Orchestra - Highlight2:22 Speaker Introduction3:25 Lessons from Championships on BusinessDiscipline, power of teamwork. Tough sport mentally and physically. Giorgetti Athletics is a non-profit organization. We teach young swimmers about water safety, teach young athletes how to achieve sports scholarships at the most competitive colleges in the U.S., reach professional leagues in Europe. Our goal is to be an inspiration for the next generation.5:15 - Secrets to 4-year Championship Streak on Italy's Water Polo Team5:59 - Team Sport is like an Orchestra Everyone needs to be connected and synchronized in the right moment or music loses its flow. Sports teams without unity lose rhythm. Unity with strong mindset is what Alex calls the magic bubble. Our winning teams during this 4-year streak won games 2 hours before we even jumped into the pool. We did not have to think or plan - we were spontaneous.8:04 - Role of Preparation, Visualization and Recovery on Winning80% of the result depends on your mindset. Visualization and Recovery are most critical9:42 What types of medical approaches did you use in those Championship teams?Cold water therapy, heart rate monitoring scans. 10:20 - Physicians were taking blood tests during 100% fatigue and pressure. This allowed our coaches to know when to rest which roles - centers who fight a lot under water. These medical analytics and tools11:44 - What role do rules and formats of competition play on the outcomes in sports and business?The pool length has shortened from 33 to 25 meters to , lower threshold for exclusions or penalties including physical contact even with one hand blocking a player.13:16 Key in Sports & Business - who is quicker to adapt & keep calm?Peace of mind. Those more calm, self-confident who understand that they have all the answers inside ultimately win.15:18 Life & Business LessonOnly 1 Good Habit can build the Best Version of Yourself

The Centers for Medicare & Medicaid Services (CMS) recently released the 2026 Medicare Physician Fee Schedule. And while that's not breaking news, the important news is that you and your team could benefit by understanding its hidden traps – so you can protect your revenue. During the next live edition of Monitor Monday, senior healthcare analyst Frank Cohen will reveal the latest developments in Medicare audit reforms and statistical extrapolation, including the Medicare Program Integrity Manuel (MPIM) standards, plus how artificial intelligence (AI) is changing audit selection for 2025.You and your team will receive expert analysis and practical guidance, as well as gain a better understanding of the true scope of improper payments.The weekly broadcast will also include these instantly recognizable features:Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.Legislative Update: Adam Brenman, senior healthcare legislative affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

This episode of the CMAJ Podcast explores how physician identity can influence patient expectations, and how those expectations may contribute to gender, race, and immigration status pay gaps. The discussion builds on the CMAJ article “Family physician pay inequality: a qualitative study exploring how physician responses to perceived patient expectations may explain gender, race, and immigration status pay differences”.Dr. Monika Dutt, a family physician, public health and preventive medicine specialist, and PhD candidate in health policy at McMaster University, explains how the study's interviews with 55 family physicians across Ontario revealed patterns linking patient expectations to physician identity. She describes how gender and cultural background influence the types of visits physicians are asked to provide, and how these interactions may affect their earnings under fee-for-service models.Dr. Meredith Vanstone, professor in the Department of Family Medicine at McMaster University, outlines how physicians adapt to explicit and inferred patient expectations and the income implications that follow. She discusses how these expectations are shaped by identity and why the resulting adjustments in care can lead to financial penalties for some physicians while improving patient relationships and trust.The guests highlight how remuneration structures can either amplify or mitigate these inequities. They suggest that moving toward salary or time-based models could help reduce the impact of physician identity on income while supporting equitable, patient-centred care.For more information from our sponsor, go to medicuspensionplan.comComments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Interview with Robyn Chalupa, PA

In this 321st episode I welcome Drs. Saddawi-Konefka, Ehrenfeld and Yu Moutier to the show to discuss how we can reduce barriers to mental health care for physicians and other health care providers, why this is so important, and concrete steps that leaders and institutions can take today. Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor and use my code accrac50off for a great deal: https://www.factor75.com* Check out Truelearn: https://tinyurl.com/ACCRACTL* Check out Uncommon Goods: https://uncommongoods.com/ACCRACAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

War begins in the human mind long before it unfolds on the battlefield. In this episode, Michael Shermer sits down with Nicholas Wright, a neurologist, neuroscientist, security strategist, and advisor to the Pentagon, to explore one of the biggest questions of our time: why do humans fight, and how does the brain shape violence, leadership, and geopolitical decision-making? Nicholas Wright is a member of the Royal Colleges of Physicians and a neuroscientist who researches the brain, technology, and security at University College London, Georgetown University, and the Center for Strategic and International Studies in Washington, DC. He worked as a neurology doctor in London and Oxford, and has published numerous academic papers which have been covered by the BBC and The New York Times. His new book is Warhead: How the Brain Shapes War and War Shapes the Brain.

✅ Silicon Valley entrepreneurship takes on a whole new meaning in this conversation with Lin Wu, whose extraordinary journey from a broom shop to a Fortune 500 technology executive embodies the true immigrant entrepreneur story, the evolution of Silicon Valley history, and the modern pressures of AI and the future of work. In this episode, we explore the insights, lessons, and pivotal moments that shaped one of the earliest engineers in Silicon Valley—and what his story means for anyone navigating today's rapidly shifting tech landscape.If you're researching how Silicon Valley really works, how careers in tech evolve, or whether innovation still lives in the Valley, this episode brings clarity. Listeners searching for how to break into tech, how AI is changing software jobs, or how immigrants succeed in entrepreneurship will hear real-world stories from someone who lived through the transistor revolution, the birth of mainframes, and the rise of venture-backed startups. Lin Wu provides candid insight into how the industry has changed—and what remains timeless.For founders, engineers, and professionals evaluating where to build their career, Lin breaks down the competitive realities of today's tech ecosystem, from tech career advice to the impact of rise of AI in tech, chip war and semiconductor industry dynamics, and the truth about cost of living in Silicon Valley. His decades of experience at IBM, Fujitsu partnerships, and startup building reveal how today's challenges mirror—and differ from—the early days of modern computing.This video helps answer key questions people frequently search:Is Silicon Valley still worth moving to?How will AI reshape software careers?Can immigrants still achieve the American Dream?How should students choose majors for the future economy?Where is the AI race between the U.S. and China actually heading?Lin Wu's wisdom offers not just answers—but perspective. You'll walk away with actionable insights on innovation, mindset, adaptability, and how to thrive as technology undergoes the biggest transition since the birth of the PC.⭐ Timestamps (15:36 total)00:00 – Introduction to Lin Wu01:00 – Immigrant beginnings and early struggles02:00 – Paying for school and first jobs in America03:00 – Entering the Ivy League and meeting IBM04:00 – Mainframe computing and the birth of Silicon Valley05:00 – Venture capital and the first startup experience06:00 – The Japanese partnership and technology transfer07:00 – Growing a company into the Fortune 50008:00 – Then vs. Now: Evolution of Silicon Valley09:00 – AI, chips, Nvidia, and the U.S.–China tech race10:00 – Remote work, Austin & Miami migrations11:00 – The American Dream then and now12:00 – How the iPhone changed tech forever13:00 – Who is winning the LLM race?14:00 – Career advice for the next generation15:00 – How to find Lin Wu's book⭐ Hashtags#SiliconValley #Entrepreneurship #LinWu #ImmigrantSuccess #AIRevolution #TechCareers #StartupLife #AmericanDream #SiliconValleyHistory #FutureOfWork #AIandTech #SemiconductorIndustry #Nvidia #TSMC #VentureCapitalTo check out the YouTube (video podcast), visit: https://www.youtube.com/@drchrisloomdphdDisclaimer: Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show.  Click here to join PodMatch (the "AirBNB" of Podcasting): https://www.joinpodmatch.com/drchrisloomdphdSubscribe to our email list: https://financial-freedom-podcast-with-dr-loo.kit.com/Thank you to all of our sponsors and advertisers that help support the show!Financial Freedom for Physicians, Copyright 2025

In this episode, I sit down with Dr. Michael Quon, a general internist and disability-inclusion advocate, to talk candidly about returning to work with disability and the real-world mechanics of getting accommodations as a physician.Michael shares his origin story, a life-altering brain injury, and the long road back—plus what he's learned about legal protections, policy gaps, and culture change in medicine.We explore why flexible scheduling and shared duty to accommodate matter ethically, legally, and for patient care—and how physicians with disabilities strengthen teams.If you've ever wondered whether you're “allowed” to ask for what you need, this one's for you.Connect with Michael:www.linkedin.com/in/MichaelJQuonLinks from Michael: Physician Health Inclusion - Community or Practice for Physicians with Disabilities and Chronic Conditionshttps://mscnorth.thinkific.com/products/communities/PHIOMA - workplace accommodations: https://www.oma.org/practice-professional-support/running-your-practice/operations-and-practice-management/human-resources-management/workplace-accommodations-for-doctors-with-disability-and-chronic-illness/The Ottawa Hospital Disability Position statement https://cjpl.ca/fostincl.htmlThe Ottawa Hospital Accommodations Policyhttps://journals.lww.com/academicmedicine/fulltext/2025/07000/implementation_of_a_policy_for_accommodations_for.10.aspxLearn more about Hippocratic Collective: https://hippocraticcollective.org/Connect on Instagram: https://www.instagram.com/joanchanmd

Hear Dr. Dalia Elimam, an Egyptian pediatrician turned energy medicine expert, speak about the wholeness she feels as she practices both conventional medicine and energy medicine.  Listen to Dr. Dalia describe:Her path of high-level conventional medicine trainingThe surprising circumstance that led her to explore energy medicineEnergy medicine from a physician's perspectiveSimple techniques you can use to calm your nervous systemFind Dr. Elimam's work at https://www.blissenergymedicinellc.com/  Kindly leave us a review so more people can discover the show, and SUBSCRIBE to receive quick access to new episodes.Follow The Alight Institute on Instagram at @alight.institute https://www.instagram.com/alight.institute/ We're happy to hear your thoughts at support@alightinstitute.com

Health attorney Dennis Hursh discusses his article "First physician employment agreement mistakes." Dennis shares his amazement after 30 years in health law at the timidity of new attending physicians during contract negotiations. He explains why the "seller's market" created by a massive physician shortage means that young doctors have far more leverage than they think. Dennis debunks the myths of the "standard contract" and the fear of "losing the job" by asking for reasonable, median compensation. This episode is a critical guide for any new physician, exploring why the employer is the "motivated buyer" and why the competition is already over once the job offer is made. Learn how to stop being competitive and start negotiating for the reasonable contract you've earned. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Disclaimer: This is a sponsored episode. Not advice. Educational purposes only. Not an endorsement for or against. Results not vetted. Views of the guests do not represent those of the host or show.  ✅ Franchising is one of the most powerful paths to predictable business ownership for doctors, dentists, attorneys, and high-income professionals looking to diversify their income and reduce dependence on W-2 income streams. In this episode, franchise expert Jon Ostenson breaks down how today's market makes non-food franchising, service-based franchises, and semi-absentee franchises uniquely attractive — especially for investors seeking scalable, operator-supported businesses.If you've been searching for how to build alternative income, how franchising compares with real estate, what franchise ROI looks like, or what types of franchises fit busy professionals, this conversation answers those exact questions. Jon explains how different franchise models solve the common frustrations professionals face: lack of time, lack of proven business systems, and the desire for passive or semi-passive income. His “executive model” approach shows how a strong operator + franchisor support can help you run a franchise without replacing your full-time career.This episode gives clarity on what franchise categories are performing well, what to avoid, what makes certain brands strong investments, and how to conduct proper franchise due diligence. Jon also shares insights from helping hundreds of investors nationwide — showing you how the right franchise can deliver strong returns, tax advantages, and long-term asset value without the risks of startups or the delays of business acquisition. ⏱️ Timestamps — 15:36 Total Runtime00:00 – Welcome + Introduction00:28 – Why franchising is exploding01:45 – Why high-income professionals are entering franchising03:02 – What to look for in a franchise04:14 – Franchise ROI vs real estate06:18 – Best industries in non-food franchising07:15 – Who is buying franchises today?08:30 – Real examples of top-performing franchises10:00 – Franchising vs startups vs acquisition12:05 – Owner-operator vs semi-absentee vs passive models13:50 – Pitfalls to avoid + how Jon helps clients14:50 – How to connect with Jon OstensonTo connect with Jon, visit: https://www.franbridgeconsulting.com/

Send me a DM here (it doesn't let me respond), OR email me: imagineabetterworld2020@gmail.comToday I'm honored to have back on the show once again: MK ULTRA, satanic ritual abuse, and organized abuse survivor, overcomer and thriver, loving mother, published writer and author, content creator and podcaster, Physician and Radiologist turned activist, Founder of the Angel Coalition and Co-Founder of Women and Children First and the Babushka Brigade, Star Fort enthusiast, award winner of the University of Washington School of Medicine's prestigious Humanitarian Award, podcast regular, and one of my dearest friends: Dr. Juliette Engel In the dark heart of 1950s America, where the CIA's MK ULTRA program spun mind control, sexual torment, and satanic ritual abuse through hidden annexes, six-year-old Juliette Engel was sold by her OSS-CIA-NSA-linked father. Raped before him as he took payment and sneered, "This is what I raised you for," her innocence shattered in a crucible of torture meant to break her mind for evil ends. Yet a divine spark endured.As a teenager, barefoot and amnesic from trauma, she escaped. With unbreakable will, she earned her medical degree, built a thriving radiology practice in Seattle, and won acclaim for her compassion. In 1992, founding the Miramed Institute in Moscow to advance women's and children's rights, she uncovered state orphanages trafficking girls - triggering memories of her own "sex magic" abuse and igniting a lifelong war on the modern slave trade.From pain rose purpose. Her ground-breaking memoir Sparky: Surviving Sex Magic, sequel Angels Over Moscow, and thriller Moscow Traffic expose truth and organized crime. Anchored by her grandmother's Lord's Prayer and faith in Christianity's power against darkness, she launched Protect Our Children, rallying communities to fight U.S. child sex trafficking - the world's top consumer - through local action and transparency.Juliette's revelations extend to star forts - ancient, star-shaped bastions engineered with sacred geometry, harmonic acoustics, and telluric energy amplification. These structures, scattered across the United States, Russia, and worldwide, were not mere defenses but thought to be advanced energy nodes in a pre-reset global grid. And this fascinating topic is what we will be discussing today - the history and relevance of star forts and how they've intertwined into Juliette's life, memories, art and advocacy. This is a topic that has never been discussed in-depth on this podcast before and I'm very excited for Juliette to do a deep dive with us on this hidden history that is a piece to the puzzle and, unexpectedly, has ties directly related to mind control and advanced technology - things we hear about often in survivor testimonies. You'll want to stick around for this groundbreaking episode!RECOMMENDED READING: -Star Forts: http://www.starforts.com/-MK ULTRA Docs https://nsarchive.gwu.edu/briefing-book/dnsa-intelligence/2024-12-23/cia-behavior-control-experiments-focus-new-scholarlyCONNECT WITH JULIETTE: Website: https://julietteengel.com/CONNECT WITH EMMA: YouTube: https://www.youtube.com/@imaginationpodcastofficialEMAIL: imagineabetterworld2020@gmail.com OR standbysurvivors@protonmail.comMy Substack: https://emmakatherine.substack.com/BUY ME A COFFEE: Support the show

The post 144 GU Infectious disease and getting more questions right appeared first on Physician Assistant Exam Review.